Skip to the page

Data / Form D filings / ProciseDX Inc.

ProciseDX Inc.: Form D filing

ProciseDX Inc., a biotechnology company in San Diego, CA, filed a Form D with the SEC in 2020. The latest, on July 31, 2020, reports $9 million sold of a $9 million offering to 20 investors.

Find out what ProciseDX Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
9449 CARROLL PARK DR, San Diego, CA, 92121
Phone
(619) 798-9698
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1819809

The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 31, 2020New notice$8,957,000$8,957,000$020Jul 17, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Magda MarquetDirector
Martin HendrixDirector
Larry MimmsExecutive Officer, Director
Larry AbensurDirector
Peter WestlakeExecutive Officer, Director

Other biotechnology companies in California that filed recently

Every Form D from the week of Jul 27, 2020 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ProciseDX Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.